Bradykinin receptor antagonists may interact with other medications that influence cardiovascular function or fluid retention. For example, when combined with ACE inhibitors, which also affect the bradykinin pathway, there may be an increased risk of angioedema. It is crucial for healthcare providers to assess potential interactions to avoid adverse outcomes.
